Hanuveda

The Science of Ayurvedic Healing

Ayurvedic Treatment of Diabetic Retinopathy

Sudden Vision Changes Require Emergency Care

Seek same-day ophthalmological assessment for: Sudden vision loss or a sudden increase in floaters, Flashes of light or a curtain-like shadow across your vision, and Severe eye pain with redness and haloes.

These may indicate retinal detachment, vitreous haemorrhage or acute glaucoma. Do not delay emergency eye treatment for Ayurvedic therapies.

Regular Diabetic Eye Screening

Diabetic retinopathy may progress without noticeable symptoms. People with diabetes should undergo regular dilated retinal examinations, at least annually when appropriate, based on their ophthalmologist’s recommendations.

Manage Blood Glucose with Eye-Safety Monitoring

Improving blood glucose control protects long-term eye health, but rapid improvement may temporarily worsen diabetic retinopathy in some patients. Those with existing retinopathy should undergo ophthalmic assessment before intensive metabolic programmes, with follow-up monitoring as advised.

Ayurveda Alongside Specialist Eye Care

Ayurvedic eye therapies may complement general eye wellness. We coordinate with ophthalmologists to support safe, individualized care and protect vision.

What the Published Research Shows

Outcome of Above Research – An integrated Ayurvedic and modern treatment approach demonstrated promising benefits in managing diabetic retinopathy (DR). The Ayurvedic intervention showed better control of fasting blood sugar and serum cholesterol, significant reduction in dot-blot and superficial retinal hemorrhages, and no observed disease progression in the treated eyes. Participants also reported improvements in physical and mental well-being, while liver and kidney function parameters remained stable. These findings highlight the potential of integrated care to support retinal health and metabolic management, although larger, long-term clinical studies are needed to confirm its effectiveness.

Outcome of Above Research – A comparative clinical study involving 45 patients reported statistically significant improvements across all three treatment groups using Doorvadya Ghrita Tarpana, Mahavasadi Kwatha, and their combined administration. Mahavasadi Kwatha demonstrated a comparatively better response in managing microaneurysms, intraretinal hemorrhages, and exudates, while combined therapy showed greater improvement in blurred vision. These findings suggest the potential of Ayurvedic interventions as supportive approaches in diabetic retinopathy management. However, no significant improvement was observed in neovascularization, and larger, long-term controlled studies are required to establish effectiveness and safety.

Outcome of Above Research – This case report highlights the potential of an integrated Ayurvedic approach in managing proliferative diabetic retinopathy. A combination of Nithya Virechana, Tarpana, Nasya, internal medicines, and dietary modifications was associated with improved visual acuity and disease stabilisation in the severely affected eye. The reported improvement suggests that comprehensive Ayurvedic care may support retinal function and help manage disease-related complications. However, as this is a single case report, larger controlled clinical studies are needed to confirm its effectiveness and long-term safety.

How Ayurveda Understands Diabetic Retinopathy

Ayurveda describes progressive visual impairment as Timira, with a staged model based on the Patala — the classical layers of the eye. The progression runs Timira → Kacha → Linganasha, from blurring through increasing opacity to loss of sight.

The Dwitiya Patala description — spots, flies and circles before the eyes — is a recognisable account of floaters, which in diabetic retinopathy signal vitreous haemorrhage. Sushruta’s description is used in contemporary Ayurvedic ophthalmology for precisely this reason.

Madhumehajanya Timira

The published Ayurvedic literature frames diabetic retinopathy as Madhumehajanya Timira — Timira arising from Madhumeha — drawing on the classical description of Timira as a complication of Prameha.

The Ayurvedic Treatment Protocol for Diabetic Retinopathy

Stage 0 — Ophthalmic assessment, which is a precondition not a formality

  • We do not treat diabetic retinopathy without an ophthalmologist involved. This is stated at the first enquiry, not discovered at the first appointment.
  • Required before we begin:
  • Dilated fundus examination with documented DR grading no apparent retinopathy, mild/moderate/severe NPDR, or proliferative DR
  • Assessment for diabetic macular oedema, with OCT where available — DMO is the commonest cause of vision loss in diabetic retinopathy and it is treatable
  • Best-corrected visual acuity, documented
  • Intraocular pressure, and assessment for neovascular glaucoma
  • Fundus photography where available, so change can be documented rather than asserted
  • Confirmation of whether laser or anti-VEGF treatment is indicated or pending
  • If sight-threatening disease is present — severe NPDR, proliferative disease, or macular oedema — the ophthalmologist treats first. We work around their schedule, not the reverse.
  • Metabolic assessment: HbA1c, duration of diabetes, blood pressure, lipid profile, renal function and urine albumin-creatinine ratio (retinopathy and nephropathy travel together), and full medication list.
  • Ayurvedic assessment: Prakriti, Vikriti, Agni, Dosha predominance, and the Avarana versus Dhatu Kshaya determination that sets the treatment sequence.
  • Baseline and repeat at 3 months and 6 months: visual acuity, DR grade, OCT central macular thickness where available, HbA1c, blood pressure, lipids.

Stage 1 — Preparatory phase

Following the sequence used in the published trial:

  • Dipana-Pachana — Trikatu, Chitrakadi Vati, Musta, to correct Agni and clear metabolic residue
  • Koshtha Shodhana — mild therapeutic purgation, gently dosed, with hydration monitored
  • Shiro Virechana / Nasya — eliminative nasal medication, at the mild end in retinopathy patients for the reasons above

Stage 2 — Snehana and systemic therapy

  • Internal Snehana with a Rasayana preparation in ghee, as used in the trial protocol
  • Sarvanga Abhyanga — for the systemic Vata component
  • Takra Dhara — used in the trial protocol; cooling, and useful for the stress and sleep component
  • Shiro Abhyanga / Shiro Pichu — gentle head therapies

Stage 3 — Netra Kriyakalpa (ocular therapies)

  • The classical eye procedures. Applied by a Shalakya Tantra-trained practitioner, with strict asepsis, and only in the appropriate stage.
  • Netra Tarpana — retention of medicated ghee over the eye within a ring; the best-known Ayurvedic eye therapy. Classically indicated in the Vata-Pitta depleted stage — not in an actively inflamed or oedematous eye. Ghritas used include Triphala Ghrita, Mahatriphala Ghrita, Jivantyadi Ghrita, Patoladi Ghrita.
  • Netra Seka / Aschyotana — ocular irrigation and eye drops
  • Anjana — collyrium
  • Putapaka — nourishing ocular therapy following Tarpana
  • Netra Pichu — medicated pad application
  • Asepsis is not optional here. These are procedures involving prolonged contact with the ocular surface in patients whose diabetes impairs healing and raises infection risk. Single-use materials, sterile preparation and trained hands.

Stage 4 — Shamana and Rasayana

  • Classical eye formulations: Triphala Ghrita, Mahatriphala Ghrita, Saptamrita Lauha, Drakshadi Kwatha, Amalaki, Triphala
  • Rasayana: Amalaki, Guduchi, Shatavari, Ashwagandha (with the liver and thyroid cautions noted on our other metabolic pages)
  • For the Prameha component: per our diabetes page

Stage 5 — The systemic programme, which is what protects your retina

  • This is where the evidence is, and we say so plainly.
  • Glycaemic control — improved steadily, not abruptly. The 76% long-term risk reduction is why; the early-worsening data are why we do it gradually in patients who already have retinopathy.
  • Blood pressure control, managed with your physician. Hypertension is associated with both presence and severity of retinopathy.
  • Lipid management — including discussing fenofibrate with your physician if you are not on it, given that it reduced progression by about a third in ACCORD Eye and cut first laser treatment by 31% in FIELD, independent of lipid effects. This is not something we prescribe; it is something worth asking about.
  • Smoking cessation.
  • Renal monitoring — retinopathy and nephropathy progress together.
  • Diet and weight management per our metabolic protocol, paced appropriately.
  • Exercise, modified — aerobic and resistance work adjusted to avoid Valsalva straining and inversions in proliferative disease.
  • Screening adherence — annual dilated examination as a minimum, more often as your ophthalmologist directs. We check at every visit whether you have been.

What Outcomes Can Be Expected

The honest frame

  • Vision already lost to diabetic retinopathy does not return. Classical Ayurveda says the same thing — Linganasha is Asadhya.
  • What can change is progression, and the interventions with demonstrated effect on progression are glycaemic control, blood pressure control, fenofibrate, laser and anti-VEGF therapy. Our contribution is helping deliver the metabolic side of that, safely, and supporting the ophthalmic side rather than competing with it.

Outcomes we consider reasonable to expect

  • Improved metabolic control, achieved at a safe pace — which is the main determinant of whether your retinopathy progresses.
  • Detection of undiagnosed or under-monitored retinopathy in patients who have not been screened. Given that retinopathy is asymptomatic until late, this is genuinely sight-preserving and it is often the most valuable thing we do.
  • Avoidance of early worsening through paced glycaemic improvement and scheduled ophthalmic review a harm prevented rather than a benefit delivered, but real.
  • Symptomatic improvement in ocular comfort dryness, strain, heaviness which Netra Kriyakalpa addresses well and which is a genuine quality-of-life matter even when it does not change the retina.
  • Possible add-on benefit on visual and clinical parameters, per the Jamnagar trial, read with the design limitations we describe above.
  • Improved sleep, stress and general wellbeing, which matter for adherence to the metabolic programme that actually protects the eye.
  • Better blood pressure and lipid management through the lifestyle programme.

Outcomes we do not claim

  • Restoration of lost vision.
  • Reversal of established retinopathy, regression of neovascularisation, or clearance of established macular oedema.
  • A substitute for anti-VEGF injections, laser photocoagulation or vitrectomy. These save sight and they are time-sensitive.
  • Avoidance of injections. Patients frequently come hoping for this. We understand why the injections are unpleasant and we will not trade your retina for your comfort.

Realistic timeline

  • Before we start: eye examination and DR grading. Where sight-threatening disease is present, ophthalmic treatment comes first and we wait.
  • Weeks 1–4: Metabolic programme begins, paced deliberately in patients with retinopathy. Ocular comfort symptoms often improve with Netra Kriyakalpa. Retinal status unchanged expected.
  • Month 3: First scheduled ophthalmic review during treatment. This is when early worsening, if it occurs, would be detected which is precisely why the review is scheduled rather than optional.
  • Months 3–6: HbA1c, blood pressure and lipids improve. Weight responds. Retinal status ideally stable.
  • Months 6–12: Second and third ophthalmic reviews, completing the 6–12 month window of elevated early-worsening risk. Metabolic gains consolidate.
  • Beyond 12 months: The benefit of good control accrues over years, not months — DCCT measured its 76% reduction over 6.5 years. Annual screening continues for life, regardless of how well your sugars are or how well you see.

How we measure it

  • Baseline, month 3 and month 6, with your ophthalmologist: best-corrected visual acuity, DR grade on dilated examination, OCT central macular thickness where available, fundus photography where available. From us: HbA1c, blood pressure, lipid profile, renal function, weight.

FAQs

No. Vision already lost to retinopathy does not return and classical Ayurveda agrees, classifying established vision loss (Linganasha) as Asadhya, incurable. What can be influenced is whether the disease progresses, and the interventions proven to do that are glycaemic control, blood pressure control, fenofibrate, laser and anti-VEGF injections. Our role is helping you achieve the metabolic side of that safely.

No, and we would not try. Anti-VEGF injections and laser save sight in macular oedema and proliferative disease, and they are time-sensitive. We understand the injections are unpleasant most people dislike them but delaying them to try something gentler first is how preventable vision loss happens. We will support you through them, not around them.

Over years, yes substantially. But in the first few months, a rapid drop can make retinopathy temporarily worse. This happens in 10–20% of patients within 3–6 months of abrupt improvement, and in roughly twice that proportion in people who already have advanced retinopathy. In mild disease it usually resolves; in advanced disease it can cause permanent damage. This is why we pace glycaemic improvement in patients with retinopathy and schedule eye reviews every three months during it. Almost no metabolic programme does this, and it is a real risk.

That combination long duration, high baseline HbA1c, large planned reduction is exactly the risk profile for early worsening. It does not mean you should not improve your control; the long-term benefit is large. It means you need an eye examination before starting, a graded rather than abrupt approach, and three-monthly eye reviews for the first six to twelve months. If your retinopathy is approaching high-risk stage, the right sequence may be laser treatment first, then intensification.

Yes, and this is the point most often missed. Diabetic retinopathy is asymptomatic until it is advanced by the time vision blurs, significant damage may already be done. Everyone with diabetes needs a dilated retinal examination at least annually regardless of symptoms or how good their control is. If you have never had one, that is more important than anything else on this page.

No go to an eye hospital today. A sudden shower of floaters can mean bleeding into the eye, and flashes or a curtain across your vision can mean retinal detachment. These need same-day ophthalmic assessment. Interestingly, Sushruta described exactly this symptom the appearance of flies, spots and circles before the eyes as a stage of Timira. He was right that it mattered. It needs a retinal surgeon, not Tarpana.

It is a well-established classical therapy and patients often find it comfortable and helpful for ocular strain and dryness. But we are careful about what we claim: it is applied to the eye's surface and surrounding structures, and the retina sits behind structures it does not reach. It was used in the published Ayurvedic retinopathy research as part of broader protocols, and it has a legitimate place but not as a treatment for retinal disease in its own right.

It is worth a conversation. In the ACCORD Eye study, fenofibrate added to a statin reduced retinopathy progression by about a third over four years, and in the FIELD trial it reduced the need for first laser treatment by 31% with the effect appearing independent of its lipid-lowering action. We do not prescribe it, but if you have diabetic retinopathy and are not on it, asking your physician whether it is appropriate for you is reasonable.

Ayurveda Hospitals for Treatment of Diabetic Retinopathy

Phone
WhatsApp
WhatsApp
Phone